Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 6.51B | 6.83B | 6.85B | 6.32B | 5.34B |
Gross Profit | 3.54B | 3.46B | 3.72B | 3.41B | 2.84B |
EBITDA | 1.87B | 1.70B | 1.91B | 1.76B | 1.23B |
Net Income | 1.29B | 1.24B | 1.25B | 1.21B | 719.00M |
Balance Sheet | |||||
Total Assets | 11.85B | 10.76B | 10.53B | 10.71B | 9.63B |
Cash, Cash Equivalents and Short-Term Investments | 1.33B | 1.59B | 1.05B | 1.57B | 1.44B |
Total Debt | 3.57B | 2.90B | 2.92B | 2.91B | 2.54B |
Total Liabilities | 5.95B | 4.92B | 5.23B | 5.32B | 4.75B |
Stockholders Equity | 5.90B | 5.84B | 5.30B | 5.39B | 4.87B |
Cash Flow | |||||
Free Cash Flow | 1.37B | 1.47B | 1.02B | 1.30B | 802.00M |
Operating Cash Flow | 1.75B | 1.77B | 1.31B | 1.49B | 921.00M |
Investing Cash Flow | -1.26B | -310.00M | -338.00M | -749.00M | -147.00M |
Financing Cash Flow | -752.00M | -930.00M | -1.37B | -696.00M | -717.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $43.48B | 49.96 | 59.33% | ― | 5.56% | 4.66% | |
77 Outperform | $176.18B | 27.01 | 13.46% | 0.35% | 2.05% | 7.03% | |
75 Outperform | $33.94B | 29.47 | 18.88% | 0.81% | 0.56% | -4.08% | |
71 Outperform | $17.77B | 27.07 | 40.82% | ― | 2.57% | 8.31% | |
68 Neutral | $141.70B | 42.03 | 6.68% | 0.58% | -3.24% | -16.60% | |
65 Neutral | $26.13B | 31.36 | -680.23% | ― | 1.18% | 12.34% | |
52 Neutral | $7.61B | 0.10 | -63.03% | 2.08% | 16.34% | 0.32% |
On July 11, 2025, Agilent Technologies announced the resignation of Robert W. McMahon, its Senior Vice President and Chief Financial Officer, effective July 31, 2025, due to personal reasons. Rodney Gonsalves, the current Vice President, Corporate Controller, and Principal Accounting Officer, will serve as interim CFO. Agilent remains confident in its long-term plans and expects its third-quarter financial results to align with previous guidance.
The most recent analyst rating on (A) stock is a Hold with a $135.00 price target. To see the full list of analyst forecasts on Agilent stock, see the A Stock Forecast page.
On May 20, 2025, Agilent Technologies announced the expansion of its Board of Directors from 10 to 12 members, appointing Pascal Soriot and Judy Gawlik Brown as new directors. Soriot, CEO of AstraZeneca, and Brown, founder of Downtown Advisory, bring extensive experience in pharmaceuticals, biotechnology, and strategic leadership, which is expected to support Agilent’s growth initiatives. The company also amended its bylaws to streamline decision-making processes. Additionally, Heidi Kunz retired from the Board after over 20 years of service, marking a significant transition in Agilent’s leadership.
The most recent analyst rating on (A) stock is a Hold with a $130.00 price target. To see the full list of analyst forecasts on Agilent stock, see the A Stock Forecast page.